105 related articles for article (PubMed ID: 26187095)
1. Kinetics and mechanisms of surface-dependent coagulation factor XII activation.
Terentyeva VA; Sveshnikova AN; Panteleev MA
J Theor Biol; 2015 Oct; 382():235-43. PubMed ID: 26187095
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional characterization of factor XII.
Tans G; Rosing J
Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
[TBL] [Abstract][Full Text] [Related]
3. Possible basis for the apparent surface selectivity of the contact activation of human blood coagulation factor XII.
Griep MA; Fujikawa K; Nelsestuen GL
Biochemistry; 1986 Oct; 25(21):6688-94. PubMed ID: 3491625
[TBL] [Abstract][Full Text] [Related]
4. Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor).
Nuijens JH; Huijbregts CC; Eerenberg-Belmer AJ; Meijers JC; Bouma BN; Hack CE
J Biol Chem; 1989 Aug; 264(22):12941-9. PubMed ID: 2473984
[TBL] [Abstract][Full Text] [Related]
5. Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor).
Tans G; Rosing J; Griffin JH
J Biol Chem; 1983 Jul; 258(13):8215-22. PubMed ID: 6553053
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
7. A model demonstrating different interactions of human coagulation factor XII (Hageman factor) with the surface at physiological and lower pH.
Samuel E; Samuel M; Villanueva GB
Biochem Mol Biol Int; 1994 Aug; 33(5):827-34. PubMed ID: 7987251
[TBL] [Abstract][Full Text] [Related]
8. Mathematical modeling of material-induced blood plasma coagulation.
Guo Z; Bussard KM; Chatterjee K; Miller R; Vogler EA; Siedlecki CA
Biomaterials; 2006 Feb; 27(5):796-806. PubMed ID: 16099033
[TBL] [Abstract][Full Text] [Related]
9. Acceleration of surface-dependent autocatalytic activation of blood coagulation factor XII by divalent metal ions.
Shore JD; Day DE; Bock PE; Olson ST
Biochemistry; 1987 Apr; 26(8):2250-8. PubMed ID: 3113477
[TBL] [Abstract][Full Text] [Related]
10. New agents for thromboprotection. A role for factor XII and XIIa inhibition.
Labberton L; Kenne E; Renné T
Hamostaseologie; 2015; 35(4):338-50. PubMed ID: 25609114
[TBL] [Abstract][Full Text] [Related]
11. Influence of Zn2+ on the kinetic events that contribute to the 500-kDa dextran-sulfate-dependent activation of factor XII (Hageman factor).
Loiseau C; Randriamahazaka HN; Nigretto JM
Eur J Biochem; 1997 May; 246(1):204-10. PubMed ID: 9210485
[TBL] [Abstract][Full Text] [Related]
12. Potential-mediated and time-controlled first order activation of factor XII (Hageman factor) adsorbed to carbon surfaces.
Randriamahazaka HN; Nigretto JM
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):567-73. PubMed ID: 7841313
[TBL] [Abstract][Full Text] [Related]
13. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
Mitropoulos KA
Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
[TBL] [Abstract][Full Text] [Related]
14. Effect of heparin on the activation of factor XII and the contact system in plasma.
Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
[TBL] [Abstract][Full Text] [Related]
15. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
[TBL] [Abstract][Full Text] [Related]
16. Factor XII (Hageman factor) is a missing link between stress and hypercoagulability and plays an important role in the pathophysiology of ischemic stroke.
Eggers AE
Med Hypotheses; 2006; 67(5):1065-71. PubMed ID: 16757126
[TBL] [Abstract][Full Text] [Related]
17. The relationship between factor VII coagulant activity and factor XII activation induced in plasma by endogenous or exogenously added contact surface.
Mitropoulos KA; Reeves BE; O'Brien DP; Cooper JA; Martin JC
Blood Coagul Fibrinolysis; 1993 Apr; 4(2):223-34. PubMed ID: 8499561
[TBL] [Abstract][Full Text] [Related]
18. Control of human coagulation by recombinant serine proteases. Blood clotting is activated by recombinant factor XII deleted of five regulatory domains.
Citarella F; Aiuti A; La Porta C; Russo G; Pietropaolo C; Rinaldi M; Fantoni A
Eur J Biochem; 1992 Aug; 208(1):23-30. PubMed ID: 1324834
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of a threshold response in a proteolytic feedback system: control of the autoactivation of factor XII.
Jesty J; Rodriguez J; Beltrami E
Pathophysiol Haemost Thromb; 2005; 34(2-3):71-9. PubMed ID: 16432309
[TBL] [Abstract][Full Text] [Related]
20. The plasma bradykinin-forming pathways and its interrelationships with complement.
Kaplan AP; Ghebrehiwet B
Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
